MenoTime™ is the first and only ovarian age clock and time to menopause predictor, validated on clinical data.
Live today. We partner with telehealth, clinics, and labs.
The ovary is the #1 lever of female healthspan, shaping risk across the whole body, from cardiometabolic disease to bone and cognitive health. Until now, there has been no good biomarker to read it.
Catch the time-sensitive window for hormone therapy initiation, before symptoms and downstream risk take hold. MenoTime stages the transition and times the conversation.
Inform egg-freezing timing, IVF versus IUI versus natural conception, and oncofertility planning with an individualized read on the ovarian reserve trajectory.
Spot rising cardiometabolic risk earlier. Ovarian age adds a signal no current biomarker delivers, guiding preventive cardiology and screening cadence.
Schedule bone-density screening, counsel on osteoporosis prevention, and contextualize cognitive health timing as estrogen declines through the transition.
MenoTime is software that reads the bloodwork you are already doing in clinic to produce a result. No new testing. No workflow disruption.
A single standard hormone panel, drawn once in routine practice. No new collection protocol and no new equipment.
Our patent-pending model returns ovarian age and time to menopause, with 95% confidence intervals on every prediction.
An easy-to-read, clinical-ready report returned instantly via simple API or reporting portal.
A clinical-grade predictor with comparable accuracy to existing clinical risk assessments.
A survival-analysis model built on gradient-boosted survival trees, running over 100,000 conditional pathways per patient. It is not generative AI and not a black box. Every prediction returns a 95% confidence interval and a ranked list of the biomarkers driving it.
MenoTime is guided and used by clinicians across OB/GYN, reproductive endocrinology, oncology, longevity, and machine learning.
Finally… ovarian age decoded. MenoTime gives women the power to turn hidden biology into better health outcomes and a longer life.
Timeless Biotech's science-forward approach to ovarian aging feels genuinely groundbreaking. MenoTime is poised to become an essential tool for women, helping us understand, support, and even hack the ovarian aging process with clarity and confidence.
MenoTime gives focus where it is long overdue. It is a chance to improve women's health through menopause and positively influence their long-term trajectory, including cognitive health.
MenoTime offers meaningful clarity during a stage of life that can feel uncertain. By providing insight into ovarian age, it lets us personalize prevention, guide medication management, and support long-term quality of life.
MenoTime gives women real, science-based insight into how their ovaries are aging. Instead of guessing, we can finally understand the menopause timeline and act early to protect hormone balance, brain and metabolic health, and longevity.
Collagen declines by nearly 30% in the first five years of menopause. If we know when that transition is starting, we can prevent the deficits before they take hold instead of just reacting to symptoms. With MenoTime, women gain the ability to protect skin, bone, brain, and heart health.
As seen in
MenoTime is live and onboarding new clinics. Add the world's only ovarian age clock to the panel you already run.